Amy Vitte
Pediatrics · Lafayette, LANPI 1306071162
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,300 of the $9,986 with a category attached, or 63.1%. Insulet Corporation accounts for 68.3% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $3,426 and has fallen 52.6% since, to $1,622 in 2025. Among pediatrics clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $43.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insulet Corporation$7K
- Dexcom, Inc.$1K
- Neurocrine Biosciences, Inc.$235
- Tolmar, Inc.$193
- Sanofi-aventis U.S. LLC$172
- Ascendis Pharma Endocrinology Inc$167
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$6,30063%
- Food & beverage$3,63636%
- Gifts$501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Insulet Corporation | 42 | $6,816 |
| Dexcom, Inc. | 106 | $1,376 |
| Neurocrine Biosciences, Inc. | 11 | $235 |
| Tolmar, Inc. | 9 | $193 |
| Sanofi-aventis U.S. LLC | 7 | $172 |
| Ascendis Pharma Endocrinology Inc | 7 | $167 |
| Medtronic | 6 | $126 |
| AbbVie | 8 | $123 |
| Tandem Diabetes Care, Inc. | 4 | $118 |
| Kyowa Kirin, Inc. | 4 | $112 |
| Xeris Pharmaceuticals, Inc. | 3 | $53 |
| Amneal Pharmaceuticals LLC | 2 | $48 |
| Soleno Therapeutics, Inc. | 2 | $45 |
| Abbott | 2 | $45 |
| Tolmar Pharmaceuticals, Inc. | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $38 |
| Endo USA, Inc. | 2 | $37 |
| Amphastar Pharmaceuticals, Inc. | 2 | $37 |
| Biomarin Pharmaceutical Inc. | 1 | $30 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Zealand Pharma US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnipod$6,300
How this compares
$9,986 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.
Other pediatrics in Lafayette
- Alicia NicklasLafayette$9K
- Kathryn ReedLafayette$6K
- Douglas GonzalesLafayette$4K
- Brian BaileyLafayette$4K
- Michael RabalaisLafayette$3K
- Elizabeth MelanconLafayette$3K
- Virginia CoreilLafayette$3K
- Melissa HebertLafayette$3K
- Corey HebertGretna$1.3M
- Katie QueenBogalusa$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.